Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Exosomes Drug Market Size
The rising cases of cancer have been driving the value of the global exosomes drug market. The number of cancer cases was close to 23.39 million in 2023. The prevalence of cancer diseases is likely to grow at the rate of 6.6% in the forecast period of 2024-2032. With this growth rate, the number of cases is likely to reach nearly 41.40 million by 2032.
Exosomes Drug Market Report Snapshots
Exosomes Drug Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The rising prevalence of cancer cases is driving the demand for exosome drugs. The prevalence of cancer cases is likely to grow at the rate of 6.6% during the forecast period of 2024-2032.
The rise in demand for drug therapy in the pharmaceutical and biopharmaceutical field is fuelled by the potential of exosome technology as a diagnostic and therapeutic tool used in the treatment of various diseases, such as neurodegeneration, cardiovascular dysfunction, and cancer.
Based on the product type, the market can be segmented into kits, reagents, and instruments.
Based on the application, the market can be segmented into biomarkers, drug delivery system, vaccine development, therapeutic agents, and others.
Based on the disease type, the market can be fragmented into cancer disease, neurodegenerative disease, cardiovascular disease, infectious disease, tissue regeneration, and others.
The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America accounting for the largest share of the market .
North America is expected to dominate the market due to excellent healthcare infrastructure, effective government policies, large base of multinational corporations, and high public awareness about diagnosis and medical assistance.
Danaher Corporation (Beckman Coulter Inc.), Hologic Inc., Lonza Group AG, Fujifilm Holdings Corporation, Miltenyi Biotec GmbH, Qiagen N.V., Thermo Fisher Scientific Inc., JSR Corporation (MBL International), Illumina, Inc., Takara Bio Inc., Malvern Instruments Ltd. (Spectris Plc Company), Abcam Plc., Ampersand Capital Partner (New England Peptide, Inc.), and Evox Therapeutics Ltd. are the top companies in the exosome drug market.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124